Hollow Brook Wealth Management’s AbbVie ABBV Stock Holding History

Hollow Brook Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$635K	Hold	2,525	–	–	0.13%	59
2026 Q1	$549K	Sell	2,525 -200	-7%	-$44.4K	0.14%	56
2025 Q4	$623K	Sell	2,725 -806	-23%	-$184K	0.16%	59
2025 Q3	$818K	Buy	3,531 +206	+6%	+$41.9K	0.19%	58
2025 Q2	$617K	Hold	3,325	–	–	0.18%	56
2025 Q1	$697K	Hold	3,325	–	–	0.2%	54
2024 Q4	$591K	Hold	3,325	–	–	0.18%	56
2024 Q3	$657K	Buy	3,325 +200	+6%	+$37.3K	0.19%	57
2024 Q2	$536K	Hold	3,125	–	–	0.18%	57
2024 Q1	$569K	Hold	3,125	–	–	0.21%	57
2023 Q4	$484K	Hold	3,125	–	–	0.19%	61
2023 Q3	$466K	Hold	3,125	–	–	0.19%	59
2023 Q2	$421K	Hold	3,125	–	–	0.18%	63
2023 Q1	$498K	Buy	3,125 +600	+24%	+$91.7K	0.24%	53
2022 Q4	$408K	Buy	2,525 +710	+39%	+$109K	0.2%	61
2022 Q3	$244K	Hold	1,815	–	–	0.14%	66
2022 Q2	$278K	Hold	1,815	–	–	0.15%	61
2022 Q1	$294K	Hold	1,815	–	–	0.13%	61
2021 Q4	$246K	Buy	+1,815	New	+$214K	0.13%	67
2013 Q4	–	Sell	-99,898	Closed	-$4.47M	–	62
2013 Q3	$4.47M	Sell	99,898 -910	-0.9%	-$40.3K	1.56%	23
2013 Q2	$4.17M	Buy	+100,808	New	+$4.41M	1.54%	24

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Hollow Brook Wealth Management's ABBV Position: Q2 2026 in Review

Hollow Brook Wealth Management held its AbbVie (ABBV) position steady in Q2 2026 at 2,525 shares worth $635K. The position accounts for 0.13% of the portfolio, ranked #59.

Hollow Brook Wealth Management first reported a position in ABBV in Q2 2013 and has held it in 21 quarters since. The position peaked at $4.47M in Q3 2013. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Hollow Brook Wealth Management held 2,525 shares of AbbVie worth $635K as of Q2 2026.
Hollow Brook Wealth Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.13% of Hollow Brook Wealth Management's portfolio in Q2 2026, its #59 holding.
Hollow Brook Wealth Management first reported a position in AbbVie in Q2 2013 and has held it in 21 quarters since.
Hollow Brook Wealth Management's AbbVie position peaked at $4.47M in Q3 2013.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Hollow Brook Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.